» Articles » PMID: 24818641

Intestinal Fatty Acid-binding Protein in Neonates with Imminent Necrotizing Enterocolitis

Overview
Journal Neonatology
Publisher Karger
Date 2014 May 14
PMID 24818641
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intestinal fatty acid-binding protein (I-FABP) is a promising marker for necrotizing enterocolitis (NEC). It can be measured in plasma (I-FABPp) and urine (I-FABPu). Data on the best way to measure I-FABP (in plasma or urine) and the necessity of simultaneous measurement of the urinary creatinine concentration to correct for physiological variations in urine concentration are not available. This holds also true for the reciprocal relation between I-FABPp, I-FABPu and other more conventional laboratory parameters.

Objectives: To evaluate the above-mentioned correlations of I-FABP measurements in neonates with suspected NEC.

Methods: All neonates with suspected NEC were prospectively included. I-FABPp and I-FABPu were analyzed at regular intervals during the first 24 h after onset of symptoms. Correlation and agreement were assessed between these and other parameters (i.e., IL-6, WBC, platelet count, CRP, pH and lactate).

Results: Included were 24 boys, 13 girls [median (range) GA 28 weeks (24-36), median birth weight 1,190 g (570-2,400)]. I-FABPu correlated strongly with I-FABPp (r 0.80, p < 0.001) with an adequate agreement. A very strong correlation between I-FABPu and I-FABPu/urine creatinine ratio (r 0.98, p < 0.001) existed. Correlations between I-FABPp/u and conventional parameters were moderate to strong until 8 h after onset of symptoms.

Conclusion: In neonates with suspected NEC, I-FABPu correlates strongly with I-FABPp, offering an opportunity to choose the most appropriate way of measuring I-FABP. Calculating urinary IFABP/creatinine ratio seems redundant. Moderately strong correlations between I-FABPu and IL-6, WBC and lactate were found.

Citing Articles

Longitudinal analysis of urinary I-FABP in extremely preterm infants that develop necrotizing enterocolitis.

Fundora J, Shores D, Everett A, Yanek L, Northington F, Gilmore M Pediatr Res. 2024; .

PMID: 39550515 DOI: 10.1038/s41390-024-03737-9.


Fatty-Acid-Binding Proteins: From Lipid Transporters to Disease Biomarkers.

Gaffar S, Aathirah A Biomolecules. 2023; 13(12).

PMID: 38136624 PMC: 10741572. DOI: 10.3390/biom13121753.


Biomarkers of gut injury in neonates - where are we in predicting necrotising enterocolitis?.

Howarth C, Banerjee J, Eaton S, Aladangady N Front Pediatr. 2022; 10:1048322.

PMID: 36518779 PMC: 9742605. DOI: 10.3389/fped.2022.1048322.


The short-term effects of RBC transfusions on intestinal injury in preterm infants.

Kalteren W, Bos A, Bergman K, van Oeveren W, Hulscher J, Kooi E Pediatr Res. 2022; 93(5):1307-1313.

PMID: 35115712 PMC: 8813571. DOI: 10.1038/s41390-022-01961-9.


Potential Role of Serum Intestinal Fatty Acid-Binding Protein as a Marker for Early Prediction and Diagnosis of Necrotizing Enterocolitis in Preterm Neonates.

Shaaban A, Alfqy O, Shaaban H, A-Maqsoud Y, Assar E J Indian Assoc Pediatr Surg. 2021; 26(6):393-400.

PMID: 34912135 PMC: 8637987. DOI: 10.4103/jiaps.JIAPS_218_20.